Melanotan II: preparation and storage
Intended for research use only. Not a medicinal product.
Contents (11 sections)
Melanotan II has an amidated C-terminus
Melanotan II, or MT-II, is a cyclic heptapeptide melanocortin analogue with N-terminal acetylation and a C-terminal amide. Its ring is a lactam, not a disulfide. PT-141, or bremelanotide, is a related but different molecule with a free C-terminal acid. Do not label MT-II as PT-141 or use one molecular weight for the other. Check cyclization, D-Phe, Nle, terminal groups and salt form. A linear precursor with similar composition is not confirmed MT-II either.
Norleucine is not methionine
Nle in the MT-II structure denotes norleucine. Do not substitute Met in a specification or calculation program. That substitution changes structure; related melanocortin analogues are not one standard. A molecular formula without cyclization and residue details does not establish every structural feature. Obtain complete identification before quantitative comparisons. Salt mass, the expected mass-spectrometric ion and peptide-component mass are also not interchangeable quantities.
Receptor binding and cell potency
Tocris reports different MT-II affinities across several melanocortin subtypes. Binding values are not automatically cAMP EC50 values in your cells. Expression, intracellular signaling and timing affect function. The catalogue table helps choose a panel but does not establish one working concentration for every subtype. For batch checks, build a curve against an appropriate standard and compare shape and maximum rather than one signal point.
Published solubility applies to a particular form
Tocris reports water solubility up to 0.7 mg/mL and dry storage at -20°C for its Melanotan II. This is a useful reference point, not a guarantee for another manufacturer’s vial with different salt, water or excipients. The arithmetic example below is not evidence of solubility in any chosen buffer. Check dilution into the final medium separately: pH, salt and proteins can change recovery. Catalogue dry-storage conditions do not establish aqueous-solution lifetime.
Mass calculations and working dilutions
An arithmetic example, not a solubility prescription: 2 mg in a final volume of 4 mL gives 0.5 mg/mL, or 500 micrograms/mL. Adding 20 microliters of that stock to 980 microliters of compatible matrix gives 10 micrograms/mL. Then 100 microliters of this solution plus 900 microliters of matrix gives 1 microgram/mL. Use the final volume in the calculation. If the certificate separately establishes peptide mass fraction, apply it according to the labeling convention, without correcting the mass twice. Molarity requires the molecular weight of the confirmed form; do not borrow a value from a related analogue.
Melanocortin subtypes give different responses
MT-II interacts with several melanocortin receptors, so protocols must specify subtype and readout. An MC1R system can assess cAMP or downstream pigmentation, but melanin accumulation also depends on time, cell condition and cell number. It is not a direct peptide-concentration measurement. MC3R, MC4R or MC5R panels require matched assay format, expression controls and timing. Compare MT-II and PT-141 within a defined system rather than extrapolating one receptor subtype’s result to every other subtype.
Pigmented matrices complicate optical checks
Pigment can affect optical readouts in melanocytes and other pigmented models. Include a matrix blank, no-peptide cells and consistent normalization by cell number or viability. More total pigment need not mean a larger response per cell. Residual MT-II measurement in the same medium requires a method separating peptide from pigment components. A colored cell sample and a color change in cell-free stock have different causes; they are not the same stability test.
Ring, light and suitability questions
Is a reductant needed to retain cyclization? Disulfide chemistry does not justify it for a lactam ring. Does cyclization eliminate oxidation sensitivity? Tryptophan and other aromatic residues remain present, so light and oxidizing conditions still need control. Can suitability be judged by color alone? Neither clarity nor a pigment response replaces chemical identification. After storage, compare chromatographic profile, recovery and the selected receptor endpoint with a fresh standard of the same form.
Light and stored-MT-II sample preparation
Keep dry MT-II sealed under the manufacturer’s freezer specification. When testing light effects on solutions, vary illumination rather than simultaneously changing temperature, container and opening time. Evaporation changes concentration without chemical conversion, so volume control matters. Assess intact peptide and receptor function separately. Recheck recovery after working dilution: water compatibility does not establish compatibility with salt- or protein-containing medium. PT-141 instructions do not establish MT-II storage lifetime despite related structures.
End of article
Melanotan II
for laboratory research
Packs and current prices on the product page.